FDA Investigator Erica L Nicoll
Erica L Nicoll has inspections in 4 countries as of 08 Nov 2023. Erica L Nicoll has collaborated with a combined 2793 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
358
Last Inspection Date:
08 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Philippines,
El Salvador,
Panama
Co-Investigator(s):
Abdellah El Hajjam,
Alex G Kalugin,
Amanda B Athey,
Amanda B Vega,
Anastasia M Shields,
Andersoneric,
Andrew E Kay,
Ann Marie Karnick,
Anna L Marroquin,
Anna L Viveros Hernandez,
Brandon L Mariner,
Brandon M Kurjanowicz,
Brian M Palermo,
Cara M Minelli,
Carl E Lovrich,
Carl Lee,
Carol A Elems,
Charles I Ann,
Christina K Theodorou,
Christopher J Lee,
Craig D Zagata,
Crayton Lee,
Cynthia F Kleppinger, MD,
Cynthia L Rakestraw,
Daniel C Geffin,
Daniel J Mechenbier,
Daniel R Rammariello,
Daniel R Tammariello,
Dauksism,
David A Lum,
David L Pearce,
Dawn D Aiello,
Deborah K Richardson,
Dennis R Hock,
Dessa A Antoine,
Dr. Mark J Seaton, PhD,
Edna J Hidalgo,
Edward R Schiffman,
Edwards,
Elizabeth B Griffin,
Elva M Ibarra,
Emil P Wang, JD,
Emmanuel O Kerry,
Erica R Pomeroy,
Erika M Wilkerson,
Erin M Holliman,
Estefania Fernandez,
Frank P Bianco,
Gayle S Lawson,
Gess,
Gladys B Casper,
Greg K Keshishyan,
Gregory E Beichner,
Gulshan R Anand,
Heika R Tait,
Helen J Hamaoka,
Herbert E Arden,
Humberto Z Gomez,
Ingrid A Zambrana,
Ismael Garibay,
James M Donner,
James M Odonnell,
Jazmine M Welcher,
Jazmine N Brown,
Jeffrey M Watson,
Jennifer L Sheehan,
Joanne M Fukuda,
John A Gonzalez,
John A Liu,
John B Crowe,
Jolene S Hedgecock,
Jonee J Mearns,
Joseph M Willems,
Joseph R Hatcher,
Joseph Tibay,
Joshua C Schafer,
Justin B Holder,
Karen A Spencer,
Karen D Phung,
Karen J Bak,
Karen M Kondas,
Karen M Willis,
Karen S Anthony,
Karla J Gibler,
Katelyn A Staub,
Katelyn Astaub Zamperini,
Kathryn A Krentz,
Katie T Duong,
Kevin P Foley,
Kimberly A Dux,
Kirk A Dymbrowski,
Lance M De Souza, MBA,
Larkin R Buckalew,
LCDR Jennifer H Rhyu,
LCDR Margaret E Digennaro,
LCDR William H Bender,
Lee,
Leongc,
Ligia M Cline,
Ligia M Sanders,
Lillian C Lopez,
Linda M Hoover,
Lindsey L Kirsh,
Lisa H Nakagawa,
Lopez,
LT John M Mastalski,
LT Mark A Chen, MPH,
LTJG Bradley E Benasutti,
Lydia S Chan,
Lynda L Perry, PhD,
Macropolk,
Marjorie D Santos,
Marjorie L Davis,
Mark E Baldwin,
Marlene L Davis,
Mary E Storch,
Mary R Kirker,
Matthew A Walburger,
Mcgrewp,
Megan E Kulas,
Michael J Diskin,
Michael R Goga,
Michael R Klapal,
Nancy E Byerly,
Nancy L Neiger,
Nikisha M Bolden,
Nisha C Patel,
Orval D Mcintire,
Paola E Lathrop,
Peter E Baker,
Phung,
Randall J Plunkett,
Randall P Zielinski,
Robert E Davis,
Robert J Waldorf,
Roberta K Smith,
Robles,
Roger D Gawne,
Ronald P Boyce,
Ruark Lanham,
Seyyida Saterfield,
Shelley H Beausoleil,
Shelley L Waring,
State Agency,
Stephen J Kilker,
Stephen J Rabe,
Steven M Galvez,
Stuart W Russell,
Tammy M Phillips,
Thomas Cote,
Thomas R Withers,
Thomas W Gordon,
Thompsonv,
Tiffani D Wilson,
Timothy C Grome,
Timothy J Schmidt,
Tomanik'e C Banks,
Tracynda L Davis,
Travelle D Mason,
Travers,
Travis R Hunt,
Van Cliff,
Victoria Taylor,
William A Warnick,
William J Weis
Erica L Nicoll's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2009 | FDA 483 | Jack E Yakish M.D. - Form 483, 2009-08-21 |
July, 2012 | EIR | Accredo Health Group, Inc. - EIR, 2012-07-24 |
January, 2013 | EIR | Promethean LifeSciences, Inc. - EIR, 2013-01-11 |
June, 2009 | FDA 483 | UNIVERSITY OF PITTSBURGH MEDICIAL CENTER CENTRALIZED PACKAGING - Form 483, 2009-06-05 |
September, 2012 | EIR | Bernard H. Doft, M.D. - EIR, 2012-09-28 |
November, 2011 | EIR | J.M. Smucker LLC - EIR, 2011-11-23 |
September, 2012 | FDA 483 Response | Bernard H. Doft, M.D. - Form 483R, 2012-10-08 |
August, 2009 | EIR | Jack E Yakish M.D. - EIR, 2009-08-21 |
January, 2013 | FDA 483 | Promethean LifeSciences, Inc. - Form 483, 2013-01-11 |
September, 2012 | FDA 483 | Bernard H. Doft, M.D. - Form 483, 2012-09-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more